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The goal of targeted therapy has driven a search for markers of prognosis and response to adjuvant therapy. The surgical resection of
a solid tumour induces tissue ischaemia and acidosis, both potent mediators of gene expression. This study investigated the impact of
colorectal cancer (CRC) surgery on prognostic and predictive marker levels. Tumour expression of thymidylate synthase, thymidine
phosphorylase, cyclin A, vascular endothelial growth factor (VEGF), carbonic anhydrase-9, hypoxia inducible factor-1a, and glucose
transporter-1 (GLUT-1) proteins was determined before and after rectal cancer surgery. Spectral imaging of tissue sections stained by
immunohistochemistry provided quantitative data. Surgery altered thymidylate synthase protein expression (P¼0.02), and this
correlated with the change in the proliferation marker cyclin A. The expression of hypoxia inducible factor-1a, VEGF, and GLUT-1
proteins was also different following surgery. Colorectal cancer surgery significantly impacts on intratumoral gene expression,
suggesting archival specimens may not accurately reflect in situ marker levels. Although rectal cancer was the studied model, the
results may be applicable to any solid tumour undergoing extirpation in which molecular markers have been proposed to guide
patient therapy.
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There has been considerable recent interest in markers of tumour
prognosis and response to adjuvant therapy in a range of tumour
types, including colorectal cancer (CRC). It is hoped these markers
will allow targeted tumour therapy while minimising the toxicity of
inefficacious agents. Thymidylate synthase (TS) is a key enzyme in
DNA synthesis and is the main site of action of the chemo-
therapeutic agent 5-fluorouracil (5-FU) (van der Wilt and Peters,
1994). It is the most widely studied prognostic and predictive
marker in CRC, with low TS levels predicting a better outcome to
5-FU based chemotherapy (Aschele et al, 2002), and high TS
expression being associated with a poor prognosis (Allegra et al,
2003). However, previous reports of TS display methodological
heterogeneity, in that TS expression within preoperative biopsies
(Okonkwo et al, 2001) as well as postoperative archival tumour
sections (Edler et al, 2000), has been correlated with treatment
outcome.
The resection of a solid tumour, such as a CRC, often involves
early clamping of the vascular pedicle to facilitate the surgical
dissection and aid tumour extirpation. Interrupting the vascular
inflow leads to tumour hypoxia and acidosis (Parkins et al, 1997),
both of which are potent mediators of gene expression (Helfman
and Falanga, 1993). In addition, delays in tissue fixation following
extirpation reduce the efficacy of subsequent protein and mRNA
analysis (Almeida et al, 2004).
We have previously shown in an experimental CRC model that
tumour vascular clamping significantly alters gene expression
levels (Atkin et al, 2006). There are no formal clinical guidelines
regarding the rapidity of tumour fixation following extirpation,
and if CRC surgery and tissue processing methods do alter gene
expression levels, it may be that marker expression in post-
operative tumour samples does not reflect true in situ levels.
Therefore, the aim of this study was to determine the effect of
surgery on marker expression in patients with CRC, looking in
particular at changes in thymidylate synthase. The relationships
between TS expression and the levels of cyclin A, a cell
proliferation marker, and the hypoxia-related protein hypoxia
inducible factor-1a (HIF-1a) are also presented.
MATERIALS AND METHODS
Study patients
Patients undergoing surgical resection of histologically proven
rectal cancer were recruited over a 2-year period. There were no
exclusion criteria. Standard curative resections and anaesthetic
techniques were performed in all cases. Local ethics committee
approval was obtained and all patients gave informed consent.
Five preoperative tumour samples were obtained on the day of
surgery, immediately prior to the surgical resection. A further five
biopsies were obtained immediately following tumour extirpation.
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sIn addition, for each patient a control sample of rectal mucosa was
obtained before and after surgery, at the same time as tumour
biopsies. Tumour and mucosal sampling was confirmed by
examination of haematoxylin and eosin stained sections by an
independent, experienced histopathologist.
Each tumour and control mucosal biopsy was stored in 10%
neutral buffered formalin solution (Sigma, Poole, UK) for
subsequent protein analysis by immunohistochemistry. For all
patients, the duration of tumour ischaemia (defined as time of
arterial pedicle clamping until postoperative biopsy) was noted, as
well as the time between extirpation and postoperative tumour
sampling. In all cases, the true clinical duration of tumour
ischaemia was longer than that noted in this study, as the
postoperative biopsies were obtained before actual fixation of the
surgical specimen by the operating theatre staff.
Immunohistochemistry
Table 1 shows the proteins and the conditions used for
immunohistochemistry. Sections (4mm) were dewaxed in xylene
for 5min and rehydrated through graded alcohol (100, 90, and
70%) to water. Heat mediated antigen retrieval was performed
using 250ml 10mM citric acid pH 6 for all markers, apart from
vascular endothelial growth factor (VEGF) (0.1 M Tris-HCL pH 10)
and CA-9 (no pretreatment), by boiling the sections in an 800W
microwave oven (Panasonic NN-6453BBPQ, 2450MHz).
For all markers apart from CA-9 and HIF-1a, sections were
transferred to the DAKO Autostaining machine (DAKO, UK)
containing peroxidase block (DAKO, S2023), the detection
reagents (ChemMate HRP, DAKO K5001), and anti-human
primary antibody diluted in antibody diluent. The Autostainer
programme included 5min in peroxidase block, 1h incubation
in primary antibody, 30min incubation in ChemMate secondary
and tertiary reagents and 5min in diaminobenzidine (DAB)
substrate.
Sections were stained for HIF-1a using the DakoCytomation
CSA II signal amplification system (DAKO Corporation, Carpin-
teria, USA). In summary, the sections were first incubated with 3%
hydrogen peroxide for 5min to quench endogenous peroxidase
activity, following which incubation with a protein block for 5min
was performed to inhibit nonspecific binding. Diluted primary
antibody was added and sections were incubated for 15min.
Sequential 15-minute incubations were performed with anti-mouse
Ig-HRP, fluorescyl-tyramide hydrogen peroxide, and antifluores-
cein-HRP. Finally, the slides were incubated for 5min with DAB/
hydrogen peroxide. For CA-9, endogenous peroxidase activity was
blocked using DAKO peroxidase block (Envision kit) for 5min.
Then a DAKO Protein Block (X0909) was added for a further
5min, following which incubation with the CA-9 primary antibody
diluted 1/50 in Tris-buffered saline for 30mins was performed.
A further incubation was then performed with DAKO Envision
HRP Mouse polymer (K4006) for 30min, followed by 5min with
DAB solution.
When the programme was complete, stained slides were
removed from the machine and counterstained in Gills
Haematoxylin (Surgipath Europe Ltd, 01500E) for 5s. Slides were
then washed in tap water, dehydrated in graded alcohols (70, 90,
and 100%), cleared in xylene and mounted in DPX (Surgipath
Europe Ltd, 08600E). Each staining run incorporated a control
slide that had previously demonstrated positive for the antibody of
interest. A negative control was also incorporated and involved the
substitution of the anti-human primary antibody for an isotypic
control antibody at the same protein concentration.
Quantification of marker protein expression
Immunohistochemical staining of marker protein expression was
quantified using a spectral imager developed and constructed in
our Institute, as reported previously (Barber et al, 2003). This
allowed accurate immunostain quantification, with stain intensity
being expressed as optical density (OD) normalised to reference
spectra. Most markers demonstrated greater expression in tumour
compared with stroma, so nonspecific background staining could
be minimised by applying arbitrary thresholds to the OD data.
For markers exhibiting similar tumour and stromal staining, a
threshold was chosen that included the staining of both tissue
compartments. In addition, the number of pixels with stain
intensity above the threshold was determined and represented
the area of the captured image demonstrating marker expression.
A standard image capture protocol was used to ensure the
maximum tumour/stroma ratio was obtained for each image,
which allowed comparison of stained area between captured
images.
Two images were captured for each of the five biopsies taken
before and after surgery, and for each captured image the stain
intensity and area were determined by spectral imaging. The
change in marker stain intensity was given by the difference
between mean stain intensity after surgery (Ma) and mean before
(Mb), whereas the change in the number of pixels demonstrating
marker expression was given by Pa–Pb. Hence, a positive
difference implies greater marker expression after surgery.
Cyclin A is a nuclear antigen and HIF-1a showed mixed nuclear
and cytoplasmic staining. Therefore, a labelling index (ratio
of positive to negative nuclei) was calculated by counting stained
cells within each captured image for HIF-1a and cyclin A, and
the change in nuclear score for these markers was given by
the difference between mean labelling index before and after
surgery.
Statistics
The Wilcoxon signed ranks test was used to determine the
magnitude of overall deviation from zero of the difference between
pre- and postoperative marker levels, where a significant devia-
tion from zero would suggest an effect of surgery on marker
expression. The sign test was used to calculate the significance of
the deviation with respect to direction. A P-value of o0.05 was
taken to represent significance. Spearman’s rank correlation
coefficient, rs, was used to determine the nonparametric correla-
tion between variables.
Table 1 Markers studied, and conditions for immunohistochemistry
Antibody Pretreatment Dilution Source of antibody
Thymidylate synthase (TS) 4 4min microwave in citric acid with 10min standing 1/300 Simon Joel, London, UK
Cyclin A 3 4min microwave in citric acid with 10min standing 1/100 #NCL-CYCLIN A, Novocastra Labs Ltd, UK
Thymidine phosphorylase (TP) None 1/400 #MS-499-P0, NeoMarkers Inc., USA
Carbonic anhydrase-9 (CA-9) None 1/50 Adrian Harris, Oxford, UK
Glucose transporter-1 (GLUT-1) 3 4min microwave in citric acid with 10min standing I/200 #A3536, DAKO Corporation, USA
Hypoxia inducible factor-1a (HIF-1a)4  4min microwave in citric acid with 20min standing 1/1000 #ab463-100, Abcam Ltd, UK
Vascular endothelial growth factor (VEGF) 3 4min microwave in Tris-HCl with 10min standing 1/100 #MS-350-P1, NeoMarkers Inc., USA
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Samples were obtained from 30 patients undergoing rectal cancer
surgery. Six patients were excluded as they had had neoadjuvant
5-FU based chemoradiation and subsequent biopsy examination
revealed no residual tumour. Therefore, data for 24 untreated
patients (median age 70, range 49–86; 16 male, 8 female) were
available for protein analysis. The patient characteristics are shown
in Table 2.
The effect of CRC surgery on tumour protein expression
The overall changes in marker stain intensity and area are given in
Figures 1A and B. Thymidylate synthase stain intensity in
postoperative biopsies was significantly different than biopsies
taken before surgery (P¼0.02), suggesting an effect of surgery on
the level of TS expression. For most patients there was a reduction
in stain intensity after surgery, but this direction of change was not
significant (16 patients with reduced expression postoperatively vs
8 patients with increased expression; P¼0.15). Thymidylate
synthase stain area also differed following surgery (P¼0.04), with
most patients showing a reduction in area (17 vs 7 patients;
P¼0.06). Surgery also reduced cyclin A expression (P¼0.01), but
the direction of change was not significant (18 vs 6 patients;
P¼0.2). The only other marker to demonstrate a change in stain
intensity following surgery was the HIF-1a nuclear count, which
increased postoperatively (magnitude: P¼0.002; direction:
P¼0.007). GLUT-1 and VEGF stain area were altered by surgery
(P¼0.004 and 0.03 respectively), with most patients showing
increased expression of GLUT-1 postoperatively (19 vs 5;
P¼0.007).
The effect of CRC surgery on control protein expression
The only marker to show altered protein expression within
samples of normal rectal mucosa was CA-9, which demonstrated
a reduction in stain area following surgery (magnitude: P¼0.009;
direction: P¼0.02).
Correlations with durations of ischaemia and extirpation,
and with the tumour level
The median duration of tumour ischaemia was 70min (range 26–
140), while the median time between extirpation and postoperative
tumour sampling was 30min (range 3–125). There was no
correlation between the change in expression and the durations
of ischaemia or extirpation for any marker studied. Correlations
for TS are given in Figures 2A and B. There was also no correlation
between the changes in stain intensity and area and the tumour
level above the anal verge. The poor correlation between changes
in hypoxic marker expression and tumour level would suggest
there was no direct relationship between ischaemic insult and the
degree of residual vascular inflow from the middle and inferior
rectal arteries following clamping of the main vascular pedicle.
Table 2 Data for patients included in the analysis
Patient
Age
(years) Sex
Tumour
level (cm
from
anus)
Histological
stage
Duration
of
ischaemia
(min)
Duration
of
extirpation
(min)
1 77 F 13 T3 N0 26 15
2 72 M 10 T3 N2 49 3
3 58 M 15 T2 N0 140 125
4 64 M 10 T3 N1 65 60
5 74 F 15 T4 N2 70 35
6 60 M 10 T3 N0 75 15
7 59 M 15 T3 N2 125 60
88 0 M 5 T 3 N 07 02 0
9 57 M 13 T3 N1 80 55
10 71 F 15 T3 N0 38 20
11 62 M 14 T3 N0 60 25
12 77 M 12 T2 N0 120 55
13 63 M 2 T2 N1 75 23
14 86 F 13 T3 N0 50 25
15 49 F 14 T2 N0 90 65
16 82 F 3 T3 N1 65 15
17 68 F 12 T3 N0 55 20
18 71 M 10 T3 N0 55 15
19 78 M 15 T3 N0 130 70
20 76 F 5 T3 N2 80 45
21 68 M 13 T3 N0 70 35
22 64 M 15 T3 N0 85 45
23 77 M 15 T3 N0 50 35
24 55 M 14 T4 N2 100 15
Median 69.5 13 70 30
Range 49–86 2–15 26–140 3–125
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Figure 1 Overall changes in marker stain intensity ((A) arbitrary units,
a.u.) and area (B) following surgery (error bars denote s.e.).
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proliferation and hypoxia
Thymidylate synthase stain area correlated with cyclin A expres-
sion (rs¼0.61, P¼0.002), suggesting changes in TS mirrored
changes in cell proliferation. Thymidylate synthase stain area also
correlated with cytoplasmic HIF-1a and GLUT-1 stain area
(rs¼0.73, Po0.0001; rs¼0.49, P¼0.02 respectively), whereas the
correlation between TS stain intensity and nuclear HIF-1a
expression approached significance (rs¼0.39, P¼0.06).
Impact of surgery on immunohistochemical visual grading
scores
Spectral imaging is a novel method of immunostain quantification,
and as such is not widely available. The most common method of
quantifying immunohistochemical staining patterns is by visual
estimation of marker stain intensity and area. Figures 3A and B
show the magnitude and direction of the changes in TS expression
after surgery in relation to these manual visual grades. The limits
for the visual grades are given in Table 3 and were derived by
analysis of a subset of patients and reported in a previous study
(Atkin et al, 2005). Although these limits are somewhat arbitrary, it
is evident the visual intensity score is different in five patients after
surgery compared with the preoperative score, whereas in six
patients the visual area grades are different postoperatively. These
visual scores are widely used to grade the expression of markers
such as TS, and in future may be involved in guiding management
decisions based on marker expression. These results suggest that
surgery may alter these visual scores, and hence there may be
discrepancies in marker expression in archival tumour samples
compared with in situ levels.
DISCUSSION
This study investigated the change in gene expression occurring
during the surgical resection of primary rectal cancer. Warm
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Figure 2 Correlation between changes in TS stain intensity (a.u.) and
duration of ischaemia ((A) rs¼0.12, P¼0.58) and extirpation ((B)
rs¼0.06, P¼0.77).
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Figure 3 The changes in TS visual stain intensity (A) and area (B) scores
occurring during CRC surgery. The length and the bearing of the arrows
represent the magnitude and direction of the change in TS expression
between pre- and postoperative biopsies.
Table 3 Spectral stain intensity and area limits for each visual grade
(visual intensity score represents overall TS stain intensity, visual area score
denotes the percentage of the section staining positively for TS)
Grade 1 2 3 4
Visual intensity score Negative Weak Moderate Strong
Spectral intensity range (a.u.) 0 0.53–0.66 0.75–0.88 0.91–1.11
Visual area score o20% 20–50% 50–75% 475%
Spectral area range (pixels 10
5) 0.02–1.1 1.7–2.4 2.5–3.1 3.7–4.0
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sischaemia has been shown to alter the gene expression profile of a
range of tissue types (Miyatake et al, 2004), and transcriptional
changes following extirpation have been demonstrated for multiple
genes within a microarray of colorectal mucosal samples beginning
20min after excision (Huang et al, 2001). Extirpation was not
shown to have an affect on DPD enzyme activity in CRC samples
(Sadahiro et al, 2003); however, delays in fixation following
excision have been shown to impair the analysis of the oestrogen
receptor (ER) status in breast cancer patients (Von Wasielewski
et al, 1998).
We found CRC surgery significantly altered intratumoural
biomarker levels, with TS showing the greatest response. There
was a trend towards a reduced expression of TS following surgery,
and it was interesting to note the correlation between TS and the
proliferation marker cyclin A, a finding also seen previously in an
experimental model of surgically induced CRC ischaemia (Atkin
et al, 2006). In fact, TS has been suggested to be a marker of cell
proliferation, as it is induced during the G1 phase of the cell cycle
and levels increase 20-fold as cells enter the S phase (Santi et al,
1974). Hypoxia slows the metabolic rate and is associated
with lower levels of transcription and translation (Dachs and
Tozer, 2000); hence, the reduction in TS levels seen after surgery
may be related to the effect of tumour ischaemia on the
proliferation status.
Thymidine phosphorylase (TP) is an enzyme involved in
thymidine homeostasis and is involved in the activation and
metabolism of the fluoropyrimidines, including 5-FU. It is also
known as platelet derived endothelial cell growth factor, and has
been shown to promote angiogenesis (Miyazono et al, 1987).
High tumour TP levels have been shown to correlate with poor
prognosis (van Triest et al, 2000), and response to 5-FU (Metzger
et al, 1998) in CRC patients. In our study, CRC surgery did not
appear to have an effect on TP expression. Previous work has
demonstrated TP protein induction by hypoxia in a breast
carcinoma cell line (Griffiths et al, 1997), but only after 16h and
there was no induction with oxygen concentrations greater than
0.3%. The same study also detected an increased TP expression
after 2h of vascular clamping in a breast tumour xenograft
model. Our data, however, suggest that the degree and duration
of tumour ischaemia is insufficient to alter TP levels in rectal
cancer patients undergoing surgery, which is an important
finding and suggests archival specimens are appropriate for
TP analysis.
The absolute intratumoral oxygen tensions were not measured
in this study, and so it is not possible to document the degree of
ischaemia for each tumour following arterial clamping. This will
vary depending on tumour level and anatomical differences in
collateral blood supply. Hypoxia-related markers were measured
in an attempt to determine the ischaemic insult. Hypoxia-inducible
factor-1 is a transcription factor involved in oxygen homeostasis. It
was noted there were changes in HIF-1a expression, with a
significant upregulation in HIF-1a nuclear protein expression
postoperatively. The cytoplasmic protein expression was unal-
tered. However, hypoxia results in translocation of the HIF-1
complex to the nucleus to allow DNA binding (Bos et al, 2004), and
so one would expect an increased differential nuclear expression.
Carbonic anhydrase-9 (CA-9) is a downstream mediator of HIF-1
activation induced by hypoxia (Wykoff et al, 2000). There were no
changes in CA-9 expression noted in this study. However, cell line
data (Lal et al, 2001) suggest the duration of ischaemia noted in
our patients was not long enough to cause CA-9 induction.
Vascular endothelial growth factor and glucose transporter-1
(GLUT-1) are also products of HIF-1 activation, and CRC surgery
did have an effect on the expression of both these markers. Taken
together, these data indicate a considerable tumour hypoxic insult
during vascular clamping.
In an experimental model of surgically induced CRC ischae-
mia, TS expression correlated directly with cyclin A and inversely
with CA-9 (Atkin et al, 2006), suggesting greater TS down-
regulation occurred at lower oxygen tensions secondary to a
decreased cell proliferation. The direct correlation between TS
and HIF-1a expression noted in this study therefore appears
paradoxical. It may be that other microenvironmental factors,
such as acidosis or alterations in the availability of glucose and
other enzymatic substrates, are more active in human tumours,
thereby affecting the level of TS or HIF-1a expression.
Alternatively, it may relate to the role of HIF-1 in hypoxia-
induced growth arrest (Goda et al, 2003), or the regulation of TS
by other factors, such as p53 or E2F-1, which are induced by
hypoxia and are involved in TS regulation (Ash et al, 1995).
It was interesting to note there was no correlation for any marker
between the change in expression and the durations of ischaemia
and extirpation, suggesting a complex interplay between gene
expression and the tumour microenvironment following vas-
cular clamping.
The findings of this study have important implications on the
timing of biomarker measurement in relation to the surgical
procedure. They suggest the need for guidelines on specimen
fixation following excision, and the importance of methodological
standardisation of studies investigating prognostic and predictive
markers, particularly if they are to be used to dictate therapeutic
strategy. The results are relevant as standard surgical techniques
were used and the tumour processing methods were those
encountered in everyday practice. In fact, the duration of tumour
ischaemia was shorter in all cases than that occurring in actual
clinical practice.
Several potential sources of error were encountered. The
tumour/stroma ratio varied between captured images, making it
difficult to compare directly the stained area between tumour
sections. However, a standard protocol for image capture was
followed, ensuring each captured image contained the maximum
available tumour tissue. Solid tumours show architectural hetero-
geneity, with varying levels of hypoxia and acidosis throughout the
tissue. This introduces sampling error when measuring gene
expression levels in biopsy specimens. This was minimised as far
as possible by multiple sampling before and after surgery, and
determining the mean marker level at each time point. Gene
expression profiles of tumour biopsies are representative of the
whole tumour (Perou et al, 2000); hence, the changes in expression
seen should be applicable to the whole lesion.
The effects of tissue processing must be considered when using
immunohistochemistry to measure marker levels. Tumour fixation
occurs at unpredictable rates, and may take days depending on the
fixative and the size of the specimen (Heyderman et al, 1989).
Similarly, protein crosslinking during tissue fixation may alter the
antigenic determinants, whereas antigen retrieval techniques may
‘unmask’ unrelated antigens (Heyderman et al, 1989). To reduce
protein degradation during processing, large specimens should be
incised to expedite fixation, or a representative tumour sample
should fixed immediately and used for subsequent protein
quantification. Alternatively, where delays in fixation are unavoid-
able, refrigeration of the specimen may minimise the loss of
immunoreactivity.
CONCLUSIONS
In patients undergoing rectal cancer surgery, significant changes
in gene expression were noted between pre- and postoperative
tumour biopsies. These findings have important considerations
when investigating prognostic markers and markers predicting
the response to adjuvant therapy. These data suggest the duration
of tumour ischaemia should be minimised prior to fixation, and
that subsequent studies need to standardise prognostic and
predictive marker measurement in relation to the surgical
procedure.
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